While some earlier studies found no prognostic value in CD8+ cell densities [9], others suggested that high tumor infiltrating lymphocyte (TIL) levels could contribute to HCC development and relapse [10]. The gene discussed is CD8A; the disease is hepatocellular carcinoma.